Effect of an association-led intervention on knowledge and compliance with regulatory practices on service provision among proprietary and patent medicine vendors in Oyo state, Nigeria.

计划入组 200 人

Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine

计划入组 20,000 人 · 首次发布于 2022 年 4 月 4 日

Retrospective Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

计划入组 12,400 人 · 首次发布于 2019 年 7 月 19 日

Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

计划入组 12,400 人 · 首次发布于 2019 年 7 月 16 日

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer

计划入组 62 人 · 首次发布于 2022 年 4 月 26 日

Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer

首次发布于 2022 年 10 月 7 日

Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction

计划入组 246 人 · 首次发布于 2025 年 4 月 27 日

National Network Genomic Medicine Lung Cancer, Germany

计划入组 30,000 人 · 首次发布于 2023 年 7 月 6 日

Study on screening of proprietary Chinese Medicine in convalescent Rehabilitation treatment of COVID-19 convalescent patients

Outcomes Mandate National Integration With Cannabis as Medicine

计划入组 200,000 人 · 首次发布于 2019 年 5 月 9 日